Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 18.


Stainthorpe, Angela ORCID: 0000-0002-2531-9371, Fleeman, Nigel ORCID: 0000-0002-4637-9779, Houten, Rachel ORCID: 0000-0002-4315-7732, Chaplin, Marty ORCID: 0000-0002-7097-8704, Boland, Angela ORCID: 0000-0002-5435-8644, Beale, Sophie ORCID: 0000-0003-0164-103X, Dundar, Yenal, McEntee, Joanne and Syndikus, Isabel
(2020) Brentuximab Vedotin for Treating Relapsed or Refractory CD30-Positive Cutaneous T-Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PHARMACOECONOMICS-OPEN, 4 (4). pp. 563-574.


Fleeman, Nigel ORCID: 0000-0002-4637-9779, Stainthorpe, Angela, Houten, Rachel ORCID: 0000-0002-4315-7732, Chaplin, Marty ORCID: 0000-0002-7097-8704, Boland, Angela ORCID: 0000-0002-5435-8644, Beale, Sophie, Dundar, Yenal, Kotas, Eleanor, McEntee, Joanne and Isabel, Syndikus
(2018) Brentuximab vedotin for treating relapsed or refractory CD30-positive cutaneous T-cell lymphoma (17/56/12). [Report]


Eldabe, Sam, Nevitt, Sarah, Griffiths, Sara, Gulve, Ashish, Thomson, Simon, Baranidharan, Ganesan, Houten, Rachel ORCID: 0000-0002-4315-7732, Brookes, Morag, Kansal, Anu, Earle, Jenny
et al (show 3 more authors) (2023) Does a Screening Trial for Spinal Cord Stimulation in Patients With Chronic Pain of Neuropathic Origin Have Clinical Utility (TRIAL-STIM)? 36-Month Results From a Randomized Controlled Trial. NEUROSURGERY, 92 (1). pp. 75-82.


Eldabe, Sam, Duarte, Rui V, Gulve, Ashish, Thomson, Simon, Baranidharan, Ganesan, Houten, Rachel ORCID: 0000-0002-4315-7732, Jowett, Susan, Sandhu, Harbinder, Chadwick, Raymond, Brookes, Morag
et al (show 7 more authors) (2020) Does a screening trial for spinal cord stimulation in patients with chronic pain of neuropathic origin have clinical utility and cost-effectiveness (TRIAL-STIM)? a randomised controlled trial. Pain, 161 (12). pp. 2820-2829.


Houten, Rachel ORCID: 0000-0002-4315-7732, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Mahon, James, Nevitt, Sarah ORCID: 0000-0001-9988-2709, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Lambe, Tosin ORCID: 0000-0002-6229-2454, Dundar, Yenal, Kotas, Eleanor and McEntee, Joanne
(2021) Encorafenib with Binimetinib for the Treatment of Patients with BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PHARMACOECONOMICS-OPEN, 5 (1). pp. 13-22.


Martin, Antony P ORCID: 0000-0003-4383-6038, Richards, Sarah, Haycox, Alan ORCID: 0000-0001-6659-4866, Houten, Rachel ORCID: 0000-0002-4315-7732, McLeod, Claire, Braithwaite, Barbara, Clark, Jack O, Bell, Joanne and Clark, Richard E ORCID: 0000-0002-1261-3299
(2016) Evaluating the use of plerixafor in stem cell mobilisation - an economic analysis of the PHANTASTIC trial. JOURNAL OF CLINICAL APHERESIS, 31 (5). pp. 434-442.


Fleeman, Nigel ORCID: 0000-0002-4637-9779, Houten, Rachel ORCID: 0000-0002-4315-7732, Bagust, Adrian ORCID: 0000-0002-2142-5767, Richardson, Marty ORCID: 0000-0002-7097-8704, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Dundar, Yenal, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Hounsome, Juliet ORCID: 0000-0002-2026-3778, Duarte, Rui
et al (show 1 more authors) (2020) Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation. HEALTH TECHNOLOGY ASSESSMENT, 24 (2). 1-+.


Chaplin, Marty ORCID: 0000-0002-7097-8704, Bresnahan, Rebecca, Fleeman, Nigel ORCID: 0000-0002-4637-9779, Mahon, James, Houten, Rachel ORCID: 0000-0002-4315-7732, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Dundar, Yenal, Marsden, Ashley and Munot, Pinki
(2023) Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15. PharmacoEconomics - Open, 7 (6). pp. 863-875.


Bresnahan, Rebecca, Houten, Rachel ORCID: 0000-0002-4315-7732, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Nevitt, Sarah ORCID: 0000-0001-9988-2709, Mahon, James, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Bhattacharyya, Devarshi, Dundar, Yenal, McEntee, Joanne
et al (show 3 more authors) (2023) Pegcetacoplan for Treating Paroxysmal Nocturnal Haemoglobinuria: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics - open, 7 (4). pp. 525-536.


Bresnahan, Rebecca, Houten, Rachel, Mahon, James, Beale, Sophie, Nevitt, Sarah, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Bhattacharyya, Devarshi, Dundar, Yenal, McEntee, Joanne and Gandhi, Shreyans
(2021) Pegcetacoplan for treating paroxysmal nocturnal haemoglobinuria [ID3746]. [Report]


Duarte, Rui V, Houten, Rachel ORCID: 0000-0002-4315-7732, Nevitt, Sarah, Brookes, Morag, Bell, Jill, Earle, Jenny, Gulve, Ashish, Thomson, Simon, Baranidharan, Ganesan, North, Richard B
et al (show 2 more authors) (2022) Screening trials of spinal cord stimulation for neuropathic pain in England-A budget impact analysis. FRONTIERS IN PAIN RESEARCH, 3. 974904-.


Duarte, Rui V, Nevitt, Sarah, Houten, Rachel ORCID: 0000-0002-4315-7732, Brookes, Morag, Bell, Jill, Earle, Jenny, Taylor, Rod S and Eldabe, Sam
(2023) Spinal Cord Stimulation for Neuropathic Pain in England From 2010 to 2020: A Hospital Episode Statistics Analysis. NEUROMODULATION, 26 (1). pp. 109-114.


Haycox, Alan ORCID: 0000-0001-6659-4866, Pirmohamed, Munir ORCID: 0000-0002-7534-7266, McLeod, Claire, Houten, Rachel ORCID: 0000-0002-4315-7732 and Richards, Sarah
(2014) Through a Glass Darkly: Economics and Personalised Medicine. PharmacoEconomics, 32 (11). pp. 1055-1061.


Chadwick, Raymond, McNaughton, Rebekah, Eldabe, Sam, Baranidharan, Ganesan, Bell, Jill, Brookes, Morag, Duarte, Rui V, Earle, Jenny, Gulve, Ashish, Houten, Rachel ORCID: 0000-0002-4315-7732
et al (show 8 more authors) (2021) To Trial or Not to Trial Before Spinal Cord Stimulation for Chronic Neuropathic Pain: The Patients' View From the TRIAL-STIM Randomized Controlled Trial. NEUROMODULATION, 24 (3). pp. 459-470.


Houten, Rachel ORCID: 0000-0002-4315-7732, Fleeman, Nigel ORCID: 0000-0002-4637-9779, Mahon, James, Chaplin, Marty ORCID: 0000-0002-7097-8704, Edwards, Katherine, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Dundar, Yenal, Marsden, Ashley, Malik, Zafar
et al (show 1 more authors) (2023) Trastuzumab Deruxtecan for Treating HER2-Positive Unresectable or Metastatic Breast Cancer After Two or More Anti-HER2 Therapies: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PHARMACOECONOMICS-OPEN, 7 (3). pp. 345-358.


Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Mahon, James, Houten, Rachel, Edwards, Katherine, Donegan, Sarah, Boland, Angela, Beale, Sophie, Dundar, Yenal and Mcentee, Joanne
(2023) Upadacitinib for treating moderately to severely active ulcerative colitis [ID3953]. [Report]


Houten, Rachel ORCID: 0000-0002-4315-7732, Fleeman, Nigel ORCID: 0000-0002-4637-9779, Kotas, Eleanor, Boland, Angela ORCID: 0000-0002-5435-8644, Lambe, Tosin ORCID: 0000-0002-6229-2454 and Duarte, Rui
(2021) A systematic review of health state utility values for thyroid cancer. QUALITY OF LIFE RESEARCH, 30 (3). pp. 675-702.


Fleeman, Nigel ORCID: 0000-0002-4637-9779, Houten, Rachel ORCID: 0000-0002-4315-7732, Chaplin, Marty ORCID: 0000-0002-7097-8704, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Dundar, Yenal, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Duarte, Rui and Shenoy, Aditya
(2019) A systematic review of lenvatinib and sorafenib for treating progressive, locally advanced or metastatic, differentiated thyroid cancer after treatment with radioactive iodine. BMC CANCER, 19 (1). 1209-.

This list was generated on Sun Mar 17 11:24:59 2024 GMT.